RIGEL PHARMACEUTICALS INC — Director's Dealing 2018

Aug 28, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2018-08-23

Reporting Person: Mayer Eldon C. III (EVP & Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-23	Common Stock	P	100000	$2.8232	Acquired	115000	Direct

Footnotes

F1: The price reported in Column 4 is the weighted average price. These shares were purchased in multiple transactions ranging from $2.78 to $2.86 Upon request, the reporting person undertakes to provide the Issuer, any security holder of the issuer, or the Securities and Exchange Commission, full information regarding the shares purchased at each such separate price.

F2: Includes 15,000 shares that were purchased by the Reporting Person under the Issuer's Employee Stock Purchase Plan, in increments of 5,000 shares, on June 30, 2017, December 29, 2017 and June 29, 2018.